Insider Transactions in Q4 2024 at Ani Pharmaceuticals Inc (ANIP)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2024
|
Stephen P. Carey SVP & CFO |
SELL
Open market or private sale
|
Direct |
7,500
-4.63%
|
$412,500
$55.79 P/Share
|
|
Dec 13
2024
|
Meredith Cook SR. VP, GENERAL COUNSEL & SEC. |
SELL
Open market or private sale
|
Direct |
250
-0.44%
|
$14,000
$56.24 P/Share
|
|
Dec 11
2024
|
Krista Davis SVP, CHIEF HR OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-2.0%
|
$60,000
$60.0 P/Share
|
|
Nov 26
2024
|
Nikhil Lalwani PRESIDENT & CEO |
SELL
Open market or private sale
|
Direct |
33,481
-4.18%
|
$1,941,898
$58.13 P/Share
|
|
Nov 26
2024
|
Nikhil Lalwani PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+6.91%
|
$870,000
$29.0 P/Share
|
|
Nov 15
2024
|
Thomas Andrew Rowland SVP, HEAD - ESTABLISHED BRANDS |
SELL
Payment of exercise price or tax liability
|
Direct |
867
-2.55%
|
$48,552
$56.58 P/Share
|
|
Nov 15
2024
|
Christopher Mutz HEAD OF RARE DISEASE |
SELL
Open market or private sale
|
Direct |
6,500
-7.81%
|
$370,500
$57.7 P/Share
|
|
Nov 13
2024
|
Meredith Cook SR. VP, GENERAL COUNSEL & SEC. |
SELL
Open market or private sale
|
Direct |
250
-0.44%
|
$15,250
$61.36 P/Share
|
|
Oct 14
2024
|
Meredith Cook SR. VP, GENERAL COUNSEL & SEC. |
SELL
Open market or private sale
|
Direct |
250
-0.44%
|
$14,250
$57.19 P/Share
|